Guy Salvesen
Overview
Explore the profile of Guy Salvesen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
2441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ashkenazi A, Salvesen G
Annu Rev Cell Dev Biol
. 2014 Aug;
30:337-56.
PMID: 25150011
Cell turnover is a fundamental feature in metazoans. Cells can die passively, as a consequence of severe damage to their structural integrity, or actively, owing to a more confined biological...
12.
Klionsky D, Abdalla F, Abeliovich H, Abraham R, Acevedo-Arozena A, Adeli K, et al.
Autophagy
. 2012 Sep;
8(4):445-544.
PMID: 22966490
In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered...
13.
X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP
Sivaraman K, Oellig C, Huynh K, Atkinson S, Poreba M, Perugini M, et al.
J Mol Biol
. 2012 Jun;
422(4):495-507.
PMID: 22709581
The malarial aminopeptidases have emerged as promising new drug targets for the development of novel antimalarial drugs. The M18AAP of Plasmodium falciparum malaria is a metallo-aminopeptidase that we show demonstrates...
14.
Uhlmann F, Salvesen G
Curr Opin Cell Biol
. 2010 Sep;
22(6):764-5.
PMID: 20864325
No abstract available.
15.
Kolli N, Mikolajczyk J, Drag M, Mukhopadhyay D, Moffatt N, Dasso M, et al.
Biochem J
. 2010 Jul;
430(2):335-44.
PMID: 20590526
The covalent attachment of SUMO (small ubiquitin-like protein modifier) to target proteins results in modifications in their activity, binding interactions, localization or half-life. The reversal of this modification is catalysed...
16.
Cimadamore F, Curchoe C, Alderson N, Scott F, Salvesen G, Terskikh A
Stem Cells
. 2009 Jun;
27(8):1772-81.
PMID: 19544437
Abundant cell death is observed when human embryonic stem cells (hESCs) undergo neuralization, a critical first step for future cell-based therapies addressing neurodegeneration. Using hESC neuralization as an in vitro...
17.
Schimmer A, Welsh K, Pinilla C, Wang Z, Krajewska M, Bonneau M, et al.
Cancer Cell
. 2004 Jan;
5(1):25-35.
PMID: 14749124
Apoptosis resistance commonly occurs in cancers, preventing activation of Caspase family cell death proteases. XIAP is an endogenous inhibitor of Caspases overexpressed in many cancers. We developed an enzyme derepression...
18.
Saklatvala J, Nagase H, Salvesen G
Biochem Soc Symp
. 2003 Nov;
(70):ix-x.
PMID: 14587277
No abstract available.
19.
Reed J, Doctor K, Rojas A, Zapata J, Stehlik C, Fiorentino L, et al.
Genome Res
. 2003 Jun;
13(6B):1376-88.
PMID: 12819136
Apoptosis (programmed cell death) plays important roles in many facets of normal mammalian physiology. Host-pathogen interactions have provided evolutionary pressure for apoptosis as a defense mechanism against viruses and microbes,...